RadNet (RDNT) Competitors

RadNet (NASDAQ:RDNT) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings, valuation and community ranking.

Do analysts rate RDNT or FMS?

RadNet currently has a consensus target price of $69.60, indicating a potential upside of 25.61%. Fresenius Medical Care has a consensus target price of $27.80, indicating a potential downside of 2.80%. Given RadNet's stronger consensus rating and higher probable upside, analysts plainly believe RadNet is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	3 Strong Buy rating(s)	3.50
Fresenius Medical Care	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has preferable earnings & valuation, RDNT or FMS?

Fresenius Medical Care has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$1.87B	2.22	$3.04M	-$0.43	-128.86
Fresenius Medical Care	$19.49B	0.86	$540.07M	$1.12	25.54

Do institutionals & insiders have more ownership in RDNT or FMS?

77.9% of RadNet shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is RDNT or FMS more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.25%	4.29%	1.45%
Fresenius Medical Care	3.43%	6.04%	2.69%

Does the media refer more to RDNT or FMS?

In the previous week, RadNet had 6 more articles in the media than Fresenius Medical Care. MarketBeat recorded 9 mentions for RadNet and 3 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.67 beat RadNet's score of 1.29 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more volatility & risk, RDNT or FMS?

RadNet has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.

Does the MarketBeat Community favor RDNT or FMS?

Fresenius Medical Care received 66 more outperform votes than RadNet when rated by MarketBeat users. However, 66.17% of users gave RadNet an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
RadNet	Outperform Votes 358 66.17%	Underperform Votes 183 33.83%
Fresenius Medical Care	Outperform Votes 424 54.64%	Underperform Votes 352 45.36%

Summary

RadNet beats Fresenius Medical Care on 10 of the 19 factors compared between the two stocks.